# Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

> **NCT00405496** · PHASE2 · COMPLETED · sponsor: **Sirion Therapeutics, Inc.** · enrollment: 24 (—)

## Conditions studied

- Anterior Uveitis

## Interventions

- **DRUG:** Difluprednate Ophthalmic Emulsion

## Key facts

- **NCT ID:** NCT00405496
- **Lead sponsor:** Sirion Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** 2001-04
- **Target enrollment:** 24 (—)
- **Last updated:** 2006-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00405496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00405496, "Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00405496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*